Evidence map›Paper›PMID 39743219›Full record

ArticleThe world journal of men's health2025

The Role of Different Modalities of Regenerative Therapies in the Treatment of Erectile Dysfunction: A Global Survey and Global Andrology Forum Expert Recommendations.

Manaf Al Hashimi, Germar-M Pinggera, Taymour Mostafa, Rupin Shah, Bahadir Sahin, Eric Chung, Amarnath Rambhatla, Selahittin Cayan, Hiva Alipour, Maged Ragab and 7 more

Abstract read
In one paragraph

Article in The world journal of men's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Manaf Al HashimiDepartment of Urology, Burjeel Hospital, Abu Dhabi, UAE.ORCID https://orcid.org/0000-0002-2458-179X
Germar-M PinggeraGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0001-6463-2494
Taymour MostafaGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0003-3627-0662
Rupin ShahGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-7868-5949
Bahadir SahinGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-4874-4178
Eric ChungGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0003-3373-3668
Amarnath RambhatlaGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-1383-6670
Selahittin CayanGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0003-4784-2208
Hiva AlipourGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-8500-4208
Maged RagabGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0003-4790-3322
Omer RaheemGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0001-6117-116X
Mohamed ArafaGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0003-0107-8857
Hussain AlnajjarGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0001-6364-0310
Ateş KadiogluGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-4239-7638
Abheesh Varma HegdeGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-2524-6889
Ahmed HarrazGlobal Andrology Forum, Moreland Hills, OH, USA.ORCID https://orcid.org/0000-0002-8902-517X
Ashok AgarwalDepartment of Urology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.ORCID https://orcid.org/0000-0003-0585-1026

Funding

Global Andrology Forum
6 · The paper itself

Abstract

purposeThere is increased interest in regenerative therapies (RTs) to treat erectile dysfunction (ED). However, the need for society's guidelines has led to varied practices. This study aims to investigate current global practices, address the heterogeneity in treatment protocols and evaluations, and establish expert recommendations in clinical practice. MATERIALS AND

methodsSenior experts from the Global Andrology Forum (GAF) created a 32-question survey to evaluate the clinical aspects of various RT modalities and compare them with each other and with phosphodiesterase type 5 inhibitors (PDE5is). The survey was distributed worldwide to ED specialists through online Google Forms, the GAF website, international professional societies, and direct emails. The responses were analyzed and are presented as percentage frequencies. Additionally, an expert consensus on recommendations for RT use was reached at via a modified Delphi method.

resultsOut of 163 respondents from 39 countries, the majority (80.1%) were using low-intensity shockwave therapy (LISWT), followed by platelet-rich plasma (PRP) 61.3% and stem cell therapy (SCT) 17.8%. Efficacy comparisons revealed no perceived significant differences among RT modalities (p=0.124). Compared to PDE5is, the efficacy of LISWT and PRP was considered lower by the respondents, while SCT was rated better by almost half of those who used SCT. The duration of improvement varied (p=0.279), with most improvements lasting 1 to 6 months. The treatment protocols used for LISWT were mainly consistent but varied widely for PRP and SCT. Adverse effects were minimal, particularly for LISWT (p<0.001). The costs varied significantly (p<0.001), with SCT being the most expensive. The evidence for efficacy was rated as primarily moderate to strong for LISWT but poor for PRP and SCT (p=0.027).

conclusionsMost respondents utilized LISWT, followed by PRP, with SCT being the least commonly utilized. The high break heterogeneity in treatment protocols and evaluation of RT underscores the need for further studies and guidelines to establish best practices.

Indexed as

Erectile dysfunctionExtracorporeal shockwave therapyPlatelet-rich plasmaRegenerative medicineStem cellsSurveys and questionnaires

Identifiers

PMID39743219
PMCPMC12505465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.